Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep100 | Bone & Osteoporosis | ECE2016

Osteoporosis and osteopenia in older Emirati men with type 2 diabetes mellitus

Almazrouei Raya A , Alkaabi Fatima M , Gayar Heba El , Lessan Nader , Barakat Maha T

Introduction: Osteoporosis is an important cause of morbidity and mortality in older men, but the extent of the problem amongst Emiratis has not been previously reported. A screening programme has been in place for older men in a large diabetes centre in the UAE, allowing patients over age 70 to have DEXA scans; we have investigated the prevalence of osteoporosis and osteopenia in this population.Methods: Data on 179 consecutive patients with type 2 diab...

ea0041ep166 | Calcium and Vitamin D metabolism | ECE2016

Hypoparathyroidism and difficult to control hypocalcemia

Alkaabi Fatima M , Almazrouei Raya A , Aldahmani Khaled M , Gayar Heba El

Introduction: Autoimmune polyglandular syndrome type 1 (APS-1) is a rare autosomal recessive disorder characterized by autoimmune multiorgan attack. Clinical manifestations are widely variable. Treatment is based on supplementation of the various deficiencies and the prognosis is variable.Case: An 18-year-old female presented with nail dystrophy and candida infection at age 7. Then, she was diagnosed with primary hyporparathyroidism and AddisonÂ’s di...

ea0038p260 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

GLP1 agonist based therapy has modest effect on weight and glycaemic control among UAE patients with diabetes: analysis of data on 3725 patients

Almazrouei Raya A , Alkaabi Fatima M , Lessan Nader , Hassan Sama , Barakat Maha T

Background and aims: GLP1 agonists are used in UAE for diabetes and obesity management (prevalence of 19 and 74% respectively). Few outcome data on GLP1 agonist therapy in this population is available. We investigated the effects of two commonly used GLP1 agonists on weight and HbA1c among UAE patients with diabetes.Materials and methods: Data was retrieved from a computerized database of patients attending a large diabetes center in UAE. Patients on exe...

ea0065p377 | Reproductive Endocrinology and Biology | SFEBES2019

A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal women

Dimakopoulou Anastasia , Jayasena Channa N , Alkaabi Fatima M , Liebers Curtis S , Handley Thomas , Franks Stephen , Dhillo Waljit S

Introduction: Over half of postmenopausal women suffer symptoms which can sometimes be non-responsive to hormone replacement therapy (HRT). Testosterone is implicated in regulating urogenital and sexual function in women. However, using testosterone therapy in postmenopausal women remains highly controversial, principally due to the lack of syndromic relationship between serum testosterone levels and onset of sexual dysfunction during menopause. Clinical practice is therefore ...